Fentiazac: Difference between revisions
CSV import |
No edit summary |
||
| Line 23: | Line 23: | ||
{{stub}} | {{stub}} | ||
<gallery> | <gallery> | ||
File:fentiazac.png|Fentiazac | File:fentiazac.png|Fentiazac | ||
File:Fentiazac-3D-balls.png|Fentiazac 3D Model | File:Fentiazac-3D-balls.png|Fentiazac 3D Model | ||
</gallery> | </gallery> | ||
Latest revision as of 21:52, 16 March 2025
Fentiazac is a nonsteroidal anti-inflammatory drug (NSAID) that was previously used for the treatment of inflammation and pain associated with rheumatic diseases and trauma. It was marketed under the brand name Rheumox by Pfizer in the UK, but is no longer available.
Pharmacology[edit]
Fentiazac is a nonsteroidal anti-inflammatory drug (NSAID), a type of medication that is commonly used to reduce inflammation and alleviate pain. Like other NSAIDs, it works by inhibiting the production of prostaglandins, chemicals in the body that cause inflammation and pain.
Medical uses[edit]
Fentiazac was used for the treatment of pain and inflammation associated with rheumatic diseases and trauma. Rheumatic diseases are conditions that affect the joints and muscles, such as rheumatoid arthritis and osteoarthritis. Trauma refers to physical injuries that can cause pain and inflammation.
Side effects[edit]
Like all NSAIDs, fentiazac can cause side effects. The most common side effects of fentiazac are gastrointestinal problems, such as nausea, vomiting, and stomach ulcers. It can also cause kidney damage in some people.
History[edit]
Fentiazac was marketed under the brand name Rheumox by Pfizer in the UK. However, it is no longer available for use.
